Apnimed, Inc. Common Stock

APMDNASDAQ • USD
22.31 USD
↗ 0.80 (3.71%)🟢PRE MARKET (AS OF 07:36 AM EDT)
🟢Market: OPEN

Apnimed, Inc. Common Stock (APMD) trades at $22.31 per share. Technical indicators currently signal "Strong Sell". This is driven by a bearish Death Cross on the long-term moving averages.

Technical & fundamental data as of Oct 2, 2026.

Open?$21.52
High?$23.06
Low?$21.52
Prev. Close?$21.51
Volume?1.3K
Avg. Volume?N/A
VWAP?$22.26
Bid / Ask
Bid?$18.49 × 100
Ask?$24.96 × 100
Spread?$6.47
Midpoint?$21.73
Valuation & Ratios
Market Cap?895.5M
Shares Out?N/A
P/E Ratio?N/A
P/B Ratio?N/A
EPS?N/A
Dividend?N/A
Ex-Dividend?N/A
News
Profile
Apnimed Inc is a late clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of novel oral therapies that address the neurobiology of sleep related breathing diseases. The company's flagship product candidate, AD109, or Oxnimbi, is an investigational, fixed-dose oral combination of a novel anti-muscarinic and selective norepinephrine reuptake inhibitor for the treatment of obstructive sleep apnea (OSA).
Employees
N/A
Market Cap
895.5M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2026-07-31
Address
39 JOHN F. KENNEDY STREET, 4TH FLR.
CAMBRIDGE, MA 02138
Phone: 617-500-8880
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?▲ Bullish(+1/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental Outlook
Loading...
Short InterestModerate
Short Interest?879.7K
Days to Cover?3.2
Avg Daily Volume271.3K
Settlement Date2026-09-15